Testing effectiveness (Phase 2)Study completedNCT01278134
What this trial is testing
RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients With Chronic Hepatitis C Genotype 1 (INFORM-SVR)
Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 170